Coupons, Prices, Copay & Patient Assistance

Learn more about WEGOVY® and see what savings options may be available to you that can help bring down the cost of your medication.

Options may include Rx Advantage Card, Copay Assistance & Coupons, Canadian Pharmacy Prices or Patient Assistance Programs. Suitable for insured, underinsured or uninsured individuals. Pay as little as $0 per fill.*

Manufactured by Novo Nordisk Inc.

*Applicable to Copay & Patient Assistance Programs

This content is intended for US audiences only

Drug savings programs

  • Qualified

    Rx Advantage Card

    A hand holding a dark-colored prescription savings card with various ID numbers and the label "Rx Advantage." Text below states the card is not insurance and cannot be used for Medicare or Medicaid.

    Save up to 90%

  • Available

    Canada Pharmacy

    Manufactured by
    Powered by
    Prescription Help Logo
  • Available

    Copay Assistance

    A hand holds a Copay Savings Card that states eligible patients with commercial insurance may pay as little as $0 per tube for Opzelura.

    Pay as little as $0

  • Unavailable

    Patient Assistance Programs

    A picture of a patient assistance application form
Jamie Winn NowPatientGreen tick
Updated on 26 Apr 2024

Learn more about WEGOVY

What is WEGOVY?

What is WEGOVY?

WEGOVY is the brand name for semaglutide and is available as a subcutaneous injection.

What dosages is WEGOVY available in?

What dosages is WEGOVY available in?

WEGOVY is available as a pre-filled, single-dose pen that delivers doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg.

What is WEGOVY used for?

What is WEGOVY used for?

WEGOVY is a GLP-1 agonist and is used for the following:
Long-term treatment for weight management in:
Adults with a body mass index (BMI) of 30 kg/m2 or greater; or BMI of 27 kg/m2 or greater and a weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol)
Children 12 years of age and older with a baseline BMI at the 95th percentile or greater Lowering the risk of heart attack, stroke, and death due to heart problems in adults with heart disease and a larger body size

How does WEGOVY work?

How does WEGOVY work?

WEGOVY is a glucagon-like peptide-1 (GLP-1) agonist. It works similarly to GLP-1, a hormone that your body normally makes that regulates your appetite. WEGOVY slows down your gut, helps you feel fuller after you eat, and controls your appetite.

How do I take WEGOVY?

How do I take WEGOVY?

WEGOVY is typically started at 0.25 mg injected under your skin once a week for 4 weeks (1 month). Your primary care provider will raise your dose every 4 weeks until you reach the maintenance dose.

The standard dosing schedule for WEGOVY might look like:

  • Month 1: Inject 0.25 mg once a week
  • Month 2: Inject 0.5 mg once a week
  • Month 3: Inject 1 mg once a week
  • Month 4: Inject 1.7 mg once a week
  • Month 5 and beyond (maintenance dose): Inject 2.4 mg once a week. Adults also have the option to inject 1.7 mg once a week as the maintenance dose
Is it safe for me to take WEGOVY?

Is it safe for me to take WEGOVY?

WEGOVY is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if any of the following apply. Personal or family history of MTC or in patients with MEN2. Known hypersensitivity to semaglutide or any of the excipients in WEGOVY.

WEGOVY Common Side Effects

WEGOVY Common Side Effects

Common side effects of WEGOVY:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Stomach pain
  • Headache
  • Tiredness
WEGOVY Serious Side Effects

WEGOVY Serious Side Effects

Serious side effects are rare with WEGOVY. Contact your healthcare provider immediately if you experience any of the following.

  • Gallbladder or pancreas problems: pain, swelling, or tenderness in the stomach; fever; yellowing of the skin or eyes
  • Serious allergic reaction: facial swelling, closing of the throat, trouble breathing, hives
  • Thoughts of self-harm
Effects of other drugs, drug classes and over-the-counter products on WEGOVY

Effects of other drugs, drug classes and over-the-counter products on WEGOVY

The following medications may interact with WEGOVY:

  • WEGOVY delays gastric emptying. May impact absorption of concomitantly administered oral medications. Use with caution
Who makes WEGOVY?

Who makes WEGOVY?

Novo Nordisk Inc.

Is WEGOVY safe in pregnancy?

Is WEGOVY safe in pregnancy?

WEGOVY may harm your unborn baby. You should
stop using WEGOVY 2 months before you plan to become pregnant. There is a pregnancy exposure registry for women who
use WEGOVY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry or you may contact Novo Nordisk at 1-877-390-2760.

US brand name of WEGOVY ® and manufacturer

Wegovy is the brand name of semaglutide and is available in the US under the brand name Wegovy. It is manufactured by Novo Nordisk

A blood test tube on a blue background at a weight loss clinic.

UK brand name of WEGOVY ® and manufacturer

Wegovy is the brand name of semaglutide and is available in the UK under the brand name Wegovy. It is also manufactured by Novo Nordisk.

Is WEGOVY ® available in the UK on the NHS?

Wegovy is available on the NHS in the UK. It can be prescribed by healthcare providers for eligible patients for weight management in line with NICE guidance, alongside increasing physical activity and following a reduced-calorie diet.

Prescription requirement for WEGOVY ®

Wegovy (semaglutide) is available as 0.25 milligrams of drug per 0.5 milliliters of solution (0.25 mg/0.5 mL), 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL.0.5 mg injection pen.  It is a prescription medicine and requires a valid prescription.

FDA approval of WEGOVY ®

Wegovy has received FDA approval for use as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in:

  • Adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related co-morbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
  • Pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity)

Limitations of use of WEGOVY ®

  • Wegovy should not be used in combination with other semaglutide-containing products or any other GLP-1 receptor agonist
  • The safety and efficacy of coadministration with other products for weight loss have not been established
  • Wegovy has not been studied in patients with a history of pancreatitis

When not to use WEGOVY ®?

There are certain precautions where Wegovy may not be suitable:

  • A stomach or intestinal disorder
  • Pancreatitis
  • Kidney disease
  • Eye problems caused by diabetes (diabetic retinopathy)
  • Have or have had depression or suicidal thoughts, or other mental health issues

You should not use Wegovy if:

  • Allergic to it or any of the ingredients. See the end of this page for a complete list of ingredients. Symptoms of a serious allergic reaction include swelling of your face, lips, tongue, or throat, problems breathing or swallowing, severe rash or itching, feeling dizzy or lightheaded, and a very rapid heartbeat
  • Multiple endocrine neoplasia type 2 (tumors in your glands) MEN2; or
  • A personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) MTC

Active ingredient of WEGOVY ® and mechanism of action

The active ingredient in Wegovy is semaglutide. Semaglutide is a man-made synthetic version of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It has 94% equivalence to human GLP-1. Wegovy works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake.

Does WEGOVY ® reduce cardiovascular risks?

Yes. The SELECT clinical trial study showed that after five years, participants taking 2.4 mg of semaglutide saw a 20% reduction in heart attacks, stroke, and heart-related deaths. These impressive cardiovascular benefits occurred regardless of adherence, or in other words, how consistently those participants of the study took Wegovy.  The SELECT clinical trial included 17,600 adults aged 45 years and older who are overweight or obese and had a prior history of heart disease but who did not have diabetes. It’s the first study to show the heart health benefits of Wegovy for people with obesity or overweight without diabetes.

Can WEGOVY ® Pen be shared?

No. You should not share your Wegovy pen with others, even if the needle is changed. You may give other people a serious infection or get a serious infection from them through cross-contamination.

Is it safe to use compounded WEGOVY ®?

The manufacturer has said that they do not sell Wegovy or the active ingredient semaglutide for compounding. Novo Nordisk is the sole company that has FDA approval to market Wegovy and it is supplied in a branded box that includes a proprietary pen along with FDA-approved prescribing information. Novo Nordisk cannot validate the safety or effectiveness of products claiming to contain semaglutide. Therefore, compounded Wegovy should be avoided.

Is there a shortage of WEGOVY ®?

Wegovy, in all strengths, is available to community pharmacies nationwide for the treatment of patients with type 2 diabetes. There may be normal delays given the time required to order the product from their local distribution center, and geographical variabilities.

Forms of WEGOVY ®

Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4mg is an injectable prescription medicine. It is available in a proprietary pen format.

Storage requirements for Wegovy

Wegovy is temperature sensitive. Patients prescribed Wegovy should store it in the refrigerator between 36 °F and 46 °F (2 °C and 8 °C). If needed, before removing the pen cap, Wegovy can be stored between 46 °F and 86 °F (8 °C and 30 °C) in the original carton for up to 28 days

WEGOVY ® dosing schedule

A diagram illustrating the stages of pregnancy.

Dosing is titrated as follows:

Start Wegovy® at a dose of 0.25 mg once a week for your first month

For your second month, you can increase your weekly dose to 0.5 mg
For your third month, you can increase your weekly dose to 1 mg
For your fourth month, you can increase your weekly dose to 1.7 mg

For the fifth month onward, you can increase your weekly dose to the full dose of 2.4 mg

It may be helpful to check in with your healthcare provider while stepping up your dose to help track your progress and what’s working for you. Be sure to talk to him or her about any side effect that bothers you or does not go away.

How long does it take for WEGOVY ® to start working?

Wegovy should be administered exactly as directed by your physician as part of your prescribed treatment plan. Treatment goals should be discussed with your healthcare provider.

How do I use the WEGOVY ® Pen?

Wegovy is used as a once-weekly injection. Your healthcare provider should show you how to use the pen. Wegovy is typically injected under the skin of your thigh, stomach, or upper arm. Wegovy must never be injected into a muscle or vein.

What happens if I stop using WEGOVY ®?

It is possible to stop and then restart Wegovy. But you will likely need to go through the full dosing schedule again.

What are the common side effects of Ozempic?

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Stomach (abdomen) pain
  • Headache
  • Tiredness (fatigue)
  • Upset stomach
  • Dizziness
  • Feeling bloated
  • Belching or gas
  • Stomach flu
  • Heartburn
  • Nausea

What are the serious side effects of Ozempic?

  • Inflammation of your pancreas (pancreatitis)
  • Gallbladder problems
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin

Contact your healthcare provider if you experience any serious side effects.

What can I do if I experience nausea when using WEGOVY ®?

  • Consume bland, low-fat foods, like crackers, toast, rice
  • Consume foods that contain water, like soups and gelatin
  • Avoid sweet foods, fried foods or greasy foods
  • Avoid laying down after eating
  • When eating, eat slowly
  • Drink ice-cold drinks

What support resources are there for WEGOVY ®?

You can speak with a Diabetes Health Coach by calling 1-833-4-WEGOVY.

What prescription assistance is available for WEGOVY ®?

If you have private or commercial insurance with coverage, you may pay as little as $0 per 28-day supply (1 box) of Wegovy subject to a maximum savings of $225 per 28-day supply for 12 fills using the savings card.

If you pay cash for your prescriptions or your commercial insurance does not cover Wegovy®, you can save up to $500 per 28-day supply (1 box) of Wegovy using the savings card.

Eligibility and other restrictions apply.

WEGOVY ® Interactions with other drugs

Ozempic may interact with certain medications, including:

  • Insulin (Humalog, Tresiba, Lantus, Basaglar)
  • Sulfonylureas
  • Antimalarial drugs (hydroxychloroquine, chloroquine)
  • Clarithromycin
  • Warfarin
  • Digoxin
  • Phenytoin


Important Information Icon

Important Information

Faq icon

Video Consultations

Now Patient Data Security

Data Security

Our Commitment to You.

Find out moreNow Patient Data SecurityNow Patient Data Security

What is NowPatient

Telehealth and Online Pharmacy

NowPatient is a licensed online pharmacy and doctor service that is available around the world. Our service is FREE and packed with valuable features that can benefit your health such as medication reminders, educational blogs, medically approved symptoms checker, UK NHS online pharmacyprivate treatment plansRx Advantage cardhealth conditions information, affordable medications options, genetic testinghome test kitshealth riskspollen meterair quality monitor, weight loss plans, drug savings programs and lots more!

Laptop showing nowpatients app dashboard


To improve the lives of everyone by making high-quality care accessible and convenient

We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

A man and woman in a video call on an iphone.

Can I trust NowPatient

Meet our medical team

We are a passionate group of clinicians and medical writers covering a broad range of specialities with experience operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process

Your Questions Answered

For your peace of mind, we can answer your questions quickly

We have a comprehensive list of FAQ’s on each feature page. Alternatively, for broader questions around our service just click the button below.
Find your answers